NEW YORK (GenomeWeb News) — A pan-European project created to discover biomarkers for monitoring and following patients with breast and colon cancer has received a €2.9 million ($3.9 million) grant from the European Union, project partner Ipsogen said today. 
 
The nine-member project, called Colon and Breast Cancer Diagnostics, or COBRED, is being coordinated by Paris-based Biosystems International, and the funding is being administered under the EU’s Sixth Framework Program.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.